Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy
Condition:   Acne Vulgaris Interventions:   Drug: Clascoterone 1% Top Cream;   Drug: Vehicle Sponsor:   Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials

Focal Prostate Ablation With Androgen Deprivation and Novel Hormonal Therapy for Intermediate Risk Prostate Cancer
Condition:   Prostate Cancer Interventions:   Drug: Apalutamide Oral Product;   Drug: Androgen Deprivation Therapy (ADT);   Procedure: Focal Therapy Sponsors:   University of Cincinnati;   Janssen, LP Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2023 Category: Research Source Type: clinical trials